TLPH (Talphera) Tariff Resilience Score: 5/10 (As of Jun. 29, 2026)


TLPH Talphera Inc TLPH
34 GF Score
Price $1.04
! 3 Warning Signs
View Full Analysis

What is Talphera Tariff Resilience Score?

Talphera TLPH +2.44% 34 Tariff Resilience Score is 5 as of Jun. 29, 2026. GuruFocus rates TLPH with a GF Score™ of 34/100. The stock has 3 warning signs investors should review. Among 1,028 Drug Manufacturers companies, Talphera ranks better than 84.63% on this metric.

Talphera has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Talphera has Talphera's exposure to tariffs depends on its industry focus. If involved in manufacturing or tech, it could face vulnerabilities, but service-oriented operations would be less affected.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Talphera might have Average Resilient.

Talphera  (NAS:TLPH) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Talphera Tariff Resilience Score Related Terms

TLPH vs CTOR, ETST, INCR: Tariff Resilience Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Talphera's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Talphera Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Talphera's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Talphera's Tariff Resilience Score falls into.


TLPH
34GF Score
Talphera Inc TLPH
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Talphera (TLPH) has a Tariff Resilience Score of 5 as of Jun. 29, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Talphera ranks #158 out of 1028 companies in the Drug Manufacturers industry, placing it in the top 15.4%.
Is Talphera's Tariff Resilience Score too high?
Talphera's current Tariff Resilience Score is 5. Based on the distribution chart, Talphera ranks #158 out of 1028 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Talphera has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Talphera's Tariff Resilience Score compare to CTOR and ETST?
According to the Drug Manufacturers industry distribution chart, Talphera ranks #158 out of 1028 companies for Tariff Resilience Score. This places Talphera in the top 15% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Talphera's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Talphera stock overvalued right now?
Talphera (TLPH) has a current Tariff Resilience Score of 5. The current Tariff Resilience Score is 5. Talphera's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Talphera (TLPH), the current Tariff Resilience Score is 5 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Talphera Business Description

Other Exchanges R5XA:Germany
Address 1850 Gateway Drive, Suite 175, San Mateo, CA, USA, 94404
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
34GF Score

Get the complete analysis for TLPH

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.04
Price